Immune checkpoint inhibitor‐mediated psoriasis treated with biologics
Abstract Skin toxicities are the most prevalent immune‐related adverse events of immune checkpoint inhibitors (ICIs), but psoriasis is uncommon. To date, there are no treatment guidelines for this unique patient cohort. We describe a case of ICI‐mediated psoriasis and its treatment using a tumour ne...
| Main Authors: | , |
|---|---|
| 格式: | 文件 |
| 语言: | English |
| 出版: |
Wiley
2023-06-01
|
| 丛编: | JEADV Clinical Practice |
| 主题: | |
| 在线阅读: | https://doi.org/10.1002/jvc2.124 |